NCT06125522
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)
Phase: Phase 1/2
Role: Collaborator
Start: Jan 10, 2024
Completion: Nov 4, 2025